PCF Science

@PCF_Science

The official Twitter account for scientific news from the Prostate Cancer Foundation. Follow us at @PCFNews @ PCF-science.bsky.social

Santa Monica, CA pcf.org Joined October 2016

660 Following 5.5K Followers 11K Posts

Latest posts 5

PCF Science @PCF_Science Jul 31

The FDA approved LuPSMA (Pluvicto) + androgen receptor pathway inhibitor therapy for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer. Approval is based on the PSMAddition trial. Congrats to everyone whose hard work led to this new option for patients!👏

FDA Drugs and Biologics Verified account @FDADrugs Jul 31

NEWS: @US_FDA approves a treatment for prostate cancer. fda.gov/drugs/resource…

View quoted post on X

PCF Science @PCF_Science Jan 16

ANNOUNCEMENT: RFA for 2026 PCF TACTICAL Award Letters Of Intent for large-scale transformative team science research projects to target mechanisms of lethal #ProstateCancer

LOI DEADLINE: March 16, 2026

View RFA: res.cloudinary.com/pcf/images/v17…
View LOI form: res.cloudinary.com/pcf/images/v17…

Prostate Cancer Foundation
2026 PCF TACTICAL Awards
Targeting Mechanisms of Lethal Prostate Cancer
REQUEST FOR LETTERS OF INTENT
IMPORTANT: Applying for a PCF TACTICAL Award (Therapy ACceleration To Intercept CAncer Lethality) involves a 2-stage process. PCF requires a Letter of Intent (LOI), followed by full application submission upon our invitation.

The Prostate Cancer Foundation (PCF) is pleased to announce a Request for LOIs for PCF TACTICAL Awards from qualified teams of investigators from academic and community institutions that will directly contribute to improved outcomes for patients with prostate cancer with lethal potential. These awards will be funded depending on the level of innovation and transformative potential in applications received. PCF seeks high-risk, currently unfunded projects from academic and community research institutions around the world. TACTICAL Awards provide $5 - $10 Million U.S.D. per award over 3–5 years.

PCF Science @PCF_Science Jan 12

ANNOUNCEMENT: RFA for 2026 @PCFnews Young Investigator Award Applications, for early career investigators dedicated to transformative research to end #ProstateCancer.

DEADLINE: Feb 23, 2026 Apply at: pcf.smartsimple.com

View the RFA: res.cloudinary.com/pcf/images/v17…

Prostate Cancer Foundation
2026 Young Investigator Awards
REQUEST FOR APPLICATIONS
The Prostate Cancer Foundation (www.pcf.org) champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer. We continue to focus significant efforts on developing gifted cohorts of young prostate cancer researchers. Since 2007, PCF has awarded 469 PCF Young Investigator Awards in 16 countries, making it one of the most prodigious, productive, competitive and prestigious early career awards in cancer research. We are pleased to announce a new round of funding for PCF Young Investigators. We especially encourage young investigators working on prostate cancer health disparities to apply.

The mission of PCF is to fund research addressing unmet medical needs in the diagnosis and treatment of potentially lethal prostate cancer.

PCF Science @PCF_Science Jan 9

Apply to join our PCF Science Team! 👇

PCF Science @PCF_Science Jan 9

ANNOUNCEMENT: RFA for 2026 @PCFnews team science Challenge Award Applications, to support investigations of #ProstateCancer with lethal potential.

DEADLINE: March 16, 2026

Apply at: pcf.smartsimple.com (portal opens on Jan 12)

View the RFA: res.cloudinary.com/pcf/images/v17…

Prostate Cancer Foundation
2026 PCF Challenge Awards
For Prostate Cancer with Lethal Potential
REQUEST FOR APPLICATIONS
The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for PCF Challenge Awards for Team Science investigations of prostate cancer with lethal potential. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic and community research institutions around the world.
PCF Challenge Awards:
• Should be composed of at least 3 investigators capable of providing unique scientific expertise to the solution of this significant problem in prostate cancer research.
• May be assembled from one institution, or several institutions.
• Must embed at least one young investigator as an integral contributor to the team. To qualify as a young investigator, this team member must have a doctoral-level degree and be within six years of completion of their terminal